View Mobile Friendly Conference List »

Conference Forum News Posts


Clinical Trials Day

Join us in celebrating Clinical Trials Day this year, on May 20, 2020, by raising clinical trial awareness and honoring clinical research professionals across the globe.

Read More »

Supporting Business Models for Scaled Connected Health Drug Delivery Products

How are industry leaders looking to bridge the gap from pilot systems to scaled solutions in the market? In this podcast, first recorded at the 2019 PODD: Partnership Opportunities in Drug Delivery conference, a panel of Connected Health leaders in the industry provide their views on how they are developing value propositions that resonate with internal […]

Read More »

Dr Moncef Slaoui Is Named Chief Advisor to White House’s Vaccine Task Force

We would like to offer our congratulations to Dr Moncef Slaoui, who has spoken at the R&D Leadership Summit and advised us on agenda development and will lead the White House’s vaccine development initiative, Project Warp Speed, to accelerate the development of a safe, effective vaccine for the novel coronavirus.  See the full press release […]

Read More »

Formulation & Device Lifecycle Management for Biotherapeutics

Subcutaneous (SC) delivery has become the norm for treating diseases such as Rheumatoid arthritis and multiple sclerosis, and there remains great potential to offer home- or even self-administered SC delivery for several other biotherapeutics. Given that there are a number of products already on the market, they can be examined to understand what improvements and […]

Read More »

New Opportunities for Cell Therapy Combinations

In this podcast moderated by Dr Michael Kalos, Janssen Oncology, you will hear a panel discussion from the 2019 IO Combinations 360° conference. Topic points include: What are the new opportunities in cell therapy for combinations? What the challenges are going to be with the microenvironment? What is being done to engineer cell therapy? How […]

Read More »

Optimizing Global Submissions in the Age of Rapidly Advancing Innovation and Rare Disease: The Challenges of Global Development

CMO Summit 360° moderator, Laurie Smaldone, MD, CMO, CSO, NDA Group, recently met via phone with Matt Ros, Chief Strategy & Business Officer, Epizyme, Adrian Senderowicz, MD, SVP, CMO, Constellation Pharmaceuticals, Christine Swenson, SVP Regulatory Affairs, Beam Therapeutics, and Haishan Xiong, PhD, MBA SVP, Business Development, Fountain Medical Development, to discuss the advantages and challenges […]

Read More »

Modality Fluid Development: Evolving Pipelines and Drug Delivery Solutions

Merck has a long history of being open to utilizing a wide range of delivery technologies for both enabling and life cycle management. In this leadership keynote, first recorded at the 2019 PODD: Partnership Opportunities in Drug Delivery conference, Dr Allen Templeton, VP, Pharmaceutical Sciences, discusses how Merck’s strategy of utilizing DDS has evolved and the role of […]

Read More »

How AI, Machine Learning and Big Data are Used to Inform Combinations

In this podcast, you will hear a panel discussion from the 2019 IO Combinations 360° conference regarding how AI, machine learning and big data are used to inform combinations. Moderated by: Matthew Albert, MD, PhD, Insitro Panelists: – Edward Bowen, GSK – Ryan Fukushima, Tempus – Renée Deehan-Kenney, PhD, QuartzBio, part of Precision for Medicine 

Read More »

Utilizing Digital Health Data to Improve Disease Management, Prevention and Overall Wellness

Given the increase in focus on digital health and connected device development to improve “patient centricity” and the user experience, there is a large amount of clarity and evidence needed on how to truly ladder in these efforts to achieve the ultimate outcome for patients. The answer lies in leveraging the power of contextualized, extrinsic […]

Read More »

Future Outlook for Novel Drug Delivery

This podcast, first recorded at the 2019 PODD: Partnership Opportunities in Drug Delivery conference explores the value of drug delivery technologies both to patients and pharma with a focus on the future direction of the field. This will include a review of the state of the art for traditional modalities such as small molecules and […]

Read More »